| Literature DB >> 31047117 |
Luis Pérez de Llano1, Eva Martínez-Moragón2, Vicente Plaza Moral3, Andrea Trisan Alonso4, Carlos Almonacid Sánchez5, Francisco Javier Callejas6, Elisabeth Vera7, Jose Gregorio Soto Campos8, Carlos Martinez Rivera9, Bernardino Alcázar Navarrete10, Isabel Urrutia Landa11, Juan Luis Garcia Rivero12, Alicia Padilla Galo13, Francisco Alvarez Gutierrez14, Pedro Landete15, Jacinto Ramos González16, Cleofé Fernández Aracil17, José Ángel Carretero Gracia18, Inmaculada Lluch19, Luis Puente20, Ruben Andujar-Espinosa21, Borja Garcia Cosío22.
Abstract
Entities:
Keywords: Control asthma; IL-8; Serum biomarkers; Severe asthma; Therapeutic goals; Treatable traits
Mesh:
Substances:
Year: 2019 PMID: 31047117 DOI: 10.1016/j.rmed.2019.03.006
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415